This is not the most recent version of the article. View current version (8 DEC 2015)
Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death
Editorial Group: Cochrane Heart Group
Published Online: 7 OCT 2009
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Claro JC, Candia R, Rada G, Larrondo F, Baraona F, Letelier LM. Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD008093. DOI: 10.1002/14651858.CD008093.
- Publication Status: New
- Published Online: 7 OCT 2009
This is not the most recent version of the article. View current version (08 DEC 2015)
This is the protocol for a review and there is no abstract. The objectives are as follows:
To evaluate the effectiveness of amiodarone as primary or secondary prevention in sudden cardiac death (SCD) compared with placebo or any other antiarrythmics in patients with high risk for sudden cardiac death, or who have recovered from a cardiac arrest or a syncope due to VT/VF. We aim to conduct a subgroup analysis for patients with or without ICD.